| Name | carnosine |
|---|---|
| Synonyms |
(2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid
N-b-Alanyl-L-histidine EINECS 206-169-9 L-Histidine, N-β-alanyl- β-Alanyl-L-histidine N-(b-Alanyl)-L-histidine N-β-Alanyl-L-histidin beta-Alanyl-L-histidine ignotine n-2-m L-IGNOTINE carnosine L-Histidine, N-(3-amino-1-hydroxypropylidene)-, (E)- karnozzn Carnosin L-Carnosine L-Histidine, β-alanyl- MFCD00005207 N-β-Alanyl-L-histidine (E)-N-(3-Amino-1-hydroxypropylidene)-L-histidine Karnozin H-β-Ala-His-OH |
| Description | L-Carnosine is a dipeptide of the amino acids beta-alanine and histidine and has the potential to suppress many of the biochemical changes that accompany aging. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vitro | L-Carnosine is a dipeptide of the amino acids beta-alanine and histidine and has the potential to suppress many of the biochemical changes that accompany aging[1]. Carnosine also exhibits some antioxidant effects. The antioxidant mechanism of carnosine is attributed to its chelating effect against metal ions, superoxide dismutase (SOD)-like activity, and ROS and free radicals scavenging ability[2]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 656.2±55.0 °C at 760 mmHg |
| Melting Point | 253 °C (dec.)(lit.) |
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.232 |
| Flash Point | 350.7±31.5 °C |
| Exact Mass | 226.106583 |
| PSA | 121.10000 |
| LogP | -2.17 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.591 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R20/21/22 |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | MS3080000 |
| HS Code | 2933290090 |
| Precursor 7 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |